MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Genetic variations in Amyloid-beta1-42 clearance proteins determine onset of dementia in Parkinson’s disease and dementia with Lewy bodies

    K. Brockmann, S. Lerche, A. Apel, A.-K. Hauser, I. Liepelt Scarfone, D. Berg, T. Gasser, C. Schulte, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate whether genetic variants in genes known to be associated with Abeta1-42 clearance contribute to the interval between ages at onset of parkinsonism…
  • 2017 International Congress

    Goalkeeper game: a novel test to identify early implicit learning alterations in people with Parkinson’s disease

    M.E. Pimentel Piemonte, A. Galves, A. Frazao Helene, M. D'Alencar (Sao Paulo, Brazil)

    Objective: To investigate the efficacy of a novel videogame to identify the early alterations in implicit learning (IL) in people with PD (PPD) Background: Although…
  • 2017 International Congress

    Use of latent class analysis and growth mixture modeling to examine longitudinal neurocognitive trajectories in non-demented Parkinson’s disease

    L. Brennan, K. Devlin, D. Mechanic-Hamilton, J. Rick, S. Xie, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: Examine the utility of latent class analysis (LCA) and growth mixture modeling (GMM) to elucidate cognitive phenotypes and longitudinal trajectories of cognitive change in…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • 2017 International Congress

    Spiral Analysis is a Promising Biomarker in LRRK2 G2019S carriers

    R. Ortega, M. Pullman, A. Glickman, I. Perera, M. San Luciano, A. Mirelman, C. Pont-Sunyer, N. Giladi, E. Tolosa, Q. Yu, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To assess whether harboring a LRRK2 G2019S mutation is associated with abnormalities in spiral drawing, including in mutation carriers with Parkinson Disease (PD) as…
  • 2017 International Congress

    Interest in Genetic Testing in Parkinson’s disease patients with DBS

    A. Fraint, G. Pal, C. Timms, E. Tam, R. Bhavsar, L. Verhagen, D. Hall, K. Marder (Chicago, IL, USA)

    Objective: To determine interest in genetic testing among Parkinson’s disease (PD) patients with deep brain stimulation (DBS). Background: Nearly 27% of patients with early-onset PD…
  • 2017 International Congress

    Genome-wide DNA methylation analysis reveals epigenetic perturbations in Parkinson disease.

    J. Young, S. Sivasankaran, L. Wang, A. Ali, A. Mehta, D. Davis, K. Belle, D. Dykxhoorn, C. Petito, G. Beecham, E. Martin, D. Mash, W. Scott, J. Vance (Miami, FL, USA)

    Objective: Several environmental exposures are known to affect the risk for PD. Because DNA methylation is affected by environmental variables, we investigated whether brain region-specific…
  • 2017 International Congress

    Genetics of impulse control disorders in Parkinson’s disease: a case control study

    J.-C. Corvol, F. Cormier-Dequaire, S. Bekadar, S. Prud'hon, M. Anheim, J.-P. Azulay, F. Durif, J.-L. Houeto, A. Destée, K. Tahiri, G. Mangone, L. Lacomblez, P. Krack, P. Krystkowiak, D. Maltête, O. Rascol, C. Tranchant, M. Vidailhet, A. Brice, S. Tezenas duMontcel (Paris, France)

    Objective: To investigate the association between candidate genes and impulse control disorders (ICD) in patients with Parkinson’s disease. Background: ICD are frequently associated with dopaminergic…
  • 2017 International Congress

    What do patients with Parkinson’s disease see in their hallucinations? Classification of hallucinations which are seen in Parkinson’s Disease; Single Center Experience

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: Our purpose is to evaluate  and classify visiual hallucination of  52 patients with Parkinson' s Disease  and to detect if there is any relation between…
  • 2017 International Congress

    Fulfilment of Movement Disorder Society clinical diagnostic criteria for Parkinson’s disease in a large cohort study of recent onset cases.

    N. Malek, M. Lawton, K. Grosset, N. Bajaj, R. Barker, Y. Ben-Shlomo, D. Burn, T. Foltynie, J. Hardy, H. Morris, N. Williams, N. Wood, D. Grosset (Ipswich, United Kingdom)

    Objective: To assess the new Movement Disorder Society (MDS) diagnostic criteria for PD. Background: Evolving knowledge regarding PD led to the development of new clinical…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley